 |
(E)-N’-(1-(5-Chloro-2-hydroxy phenyl)Ethylidene)-3-((4-Methyl Piperazin-1-yl) Sulfonyl) Benzohydrazide Mesylate |
|---|---|
| Trade Name | |
| Orphan Indication | Ewing's sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-12 00:00:00 |
| Sponsor | Salarius Pharmaceuticals;2450 Holcombe Boulevard, Suite J-608;Houston, Texas, 77021 |
